Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Redox-sensitive protein cysteine residues are chemically unique amino acids within proteins that undergo reversible oxidation-reduction (redox) modifications, acting as dynamic "sensors" and regulatory switches for cellular processes[2][3]. The sulfur-containing thiol (-SH) group of cysteine enables it to participate in electron transfer, form disulfide bonds, and be modified by cellular oxidants (reactive oxygen and nitrogen species), which can alter protein conformation, activity, localization, or interactions[2][3]. Notably, these modifications regulate major cellular processes including signal transduction, cytoprotection, apoptosis, and cell metabolism. In some proteins (e.g., p53, Src family kinases), specific cysteine residues are critical for structural integrity, metal ion coordination, and response to cellular stress[1][2]. Dysregulated modification of redox-sensitive cysteines under pathological oxidative stress contributes to diseases such as cancer, diabetes, neurodegeneration, and cardiovascular disorders[2][3]. These residues are not themselves drug targets, but specific protein cysteine residues are increasingly recognized as critical sites for drug action or biomarker development.
- Covalent modification of cysteine in target proteins (e.g., S-nitrosylation, S-glutathionylation by endogenous oxidants or therapeutics) - Inhibition by targeted small molecules that alkylate/react with cysteine in protein active sites - Indirect modulation via oxidoreductases (e.g., thioredoxin, glutaredoxin)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Redox-sensitive protein cysteine residue.